In a rat model of bladder cancer triggered by N-butyl-4-N-(4-hydroxybutyl) nitrosamine, the level of COX-2 is also shown to be increased along with higher expression of PGE27,8. Here, PTGS2 is linked to urinary bladder carcinoma.